Title |
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
|
---|---|
Published in |
Leukemia, October 2018
|
DOI | 10.1038/s41375-018-0268-9 |
Pubmed ID | |
Authors |
Jan Braess, Susanne Amler, Karl-Anton Kreuzer, Karsten Spiekermann, Hans Walter Lindemann, Eva Lengfelder, Ullrich Graeven, Peter Staib, Wolf-Dieter Ludwig, Harald Biersack, Yon-Dschun Ko, Michael J. Uppenkamp, Maike De Wit, Stefan Korsten, Rudolf Peceny, Tobias Gaska, Xaver Schiel, Dirk M. Behringer, Michael G. Kiehl, Bettina Zinngrebe, Gerald Meckenstock, Eva Roemer, Dirk Medgenberg, Ernst Spaeth-Schwalbe, Gero Massenkeil, Heidrun Hindahl, Rainer Schwerdtfeger, Guido Trenn, Cristina Sauerland, Raphael Koch, Martin Lablans, Andreas Faldum, Dennis Görlich, Stefan K. Bohlander, Stephanie Schneider, Annika Dufour, Christian Buske, Michael Fiegl, Marion Subklewe, Birgit Braess, Michael Unterhalt, Anja Baumgartner, Bernhard Wörmann, Dietrich Beelen, Wolfgang Hiddemann |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 20% |
United States | 1 | 10% |
Jordan | 1 | 10% |
Saudi Arabia | 1 | 10% |
Unknown | 5 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 50% |
Practitioners (doctors, other healthcare professionals) | 3 | 30% |
Scientists | 1 | 10% |
Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 16% |
Other | 3 | 6% |
Student > Bachelor | 3 | 6% |
Student > Master | 3 | 6% |
Student > Ph. D. Student | 3 | 6% |
Other | 9 | 18% |
Unknown | 20 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 31% |
Nursing and Health Professions | 4 | 8% |
Engineering | 4 | 8% |
Social Sciences | 2 | 4% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Other | 4 | 8% |
Unknown | 19 | 39% |